Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health ...
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
In this episode titled, Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical ...
Evaluating quality of life (QOL) in patients with idiopathic pulmonary fibrosis (IPF) goes beyond lung function numbers. It also shows how treatments affect daily well-being and guides funding, ...
Stroke patients face unequal access to clot-removal care; race and insurance shape transfers, even with Medicare—here’s what must change, according to Luke Messac, MD, PhD. Disparities in access to ...
The rationale behind the treatment is that because genetic FXI deficiency has been linked with reduced risk of ischemic ...
First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, ...
Under terms announced December, Cencora acquired shares in OneOncology from TPG and other shareholders for approximately $3.6 ...
According to Express Scripts, its new pharmacy benefits model, first announced in October 2025, could lower brand name ...
ED dizziness visits see rising MRI use at discharge; exam-guided imaging helps detect missed strokes and informs secondary ...
Oral Wegovy shifts GLP-1 obesity costs: insurance may match injectables, while cash-pay and pharmacy platforms unlock lower ...
Linda Stein Gold, MD, shares insights on new therapeutic options for patients with various psoriasis subtypes and psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results